Literature DB >> 3384008

Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance.

E Contreras1, L Tamayo, M Amigo.   

Abstract

The influence of calcium channel blockers on morphine-induced analgesia and on tolerance to the chronic administration of the opiate was investigated in mice. The effects of a test dose of morphine were significantly increased by the administration of diltiazem, flunarizine, nicardipine and verapamil. In contrast, nifedipine induced an antagonistic effect. The calcium channel antagonists did not change the reaction time to thermal stimulation in mice (hot plate test). The administration of nifedipine, flunarizine and verapamil reduced the intensity of the tolerance induced by a single dose of morphine administered in a slow release preparation. Diltiazem induced a non-significant decrease of the process. The present results are in accordance with the known interaction of acute and chronic morphine administration with the intracellular calcium concentration in neurones of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384008     DOI: 10.1016/0014-2999(88)90129-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Role of calcium channels in effects of antidepressant drugs on responsiveness to pain.

Authors:  L Antkiewicz-Michaluk; I Romańska; J Michaluk; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Calcium channel blockers: effect on morphine-induced hypermotility.

Authors:  M I Martin; I Lizasoain; J C Leza
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Enhanced analgesic effect of morphine-nimodipine combination after intraspinal administration as compared to systemic administration in mice.

Authors:  Dilip Verma; Subrata Basu Ray; Ishan Patro; Shashi Wadhwa
Journal:  J Biosci       Date:  2005-09       Impact factor: 1.826

Review 5.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 6.  The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats.

Authors:  T J Coderre
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

7.  Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine.

Authors:  L Antkiewicz-Michaluk; J Michaluk; I Romańska; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.

Authors:  J V Garaulet; M L Laorden; M V Milanés
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

9.  Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening.

Authors:  D Smart; G Smith; D G Lambert
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

10.  Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats.

Authors:  F Ruiz; M Dierssen; J Flórez; M A Hurlé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.